Atlas Trials

Stage IV Bladder Urothelial Carcinoma AJCC v7

8 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage IV Bladder Urothelial Carcinoma AJCC v7

RecordFirmDate
Nivolumab and RT in Treating Patients With Localized/Locally Advanced Urothelial Bladder Cancer Ineligible for Chemo (NCT03421652)Barbara Ann Karmanos Cancer Institute2018-04-24
Sapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mutations (NCT03047213)National Cancer Institute (NCI)2017-08-24
Cisplatin and Gemcitabine Hydrochloride With or Without Berzosertib in Treating Patients With Metastatic Urothelial Cancer (NCT02567409)National Cancer Institute (NCI)2017-01-31
Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or Cannot Be Removed by Surgery (NCT02178241)National Cancer Institute (NCI)2014-12-11
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer (NCT01050504)University of Washington2009-08-01
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer (NCT00942331)National Cancer Institute (NCI)2009-07-15

Track Stage IV Bladder Urothelial Carcinoma AJCC v7 automatically

Every clearance here is in the API, with alerts when new ones post.